Table 1 Participant characteristics at baseline
| Â | N |
|---|---|
Participants, total | 23 |
Age, range (mean) | 38–64y (55y) |
Menopausal status | |
 Premenopausal | 8 (35%) |
 Postmenopausal | 15 (65%) |
Employment | |
 Self-employed | 3 (13%) |
 Upper-level employees | 4 (17%) |
 Lower-level employees | 6 (26%) |
 Manual workers | 1 (4%) |
 Students | 0 (0%) |
 Pensioners, housewives | 3 (13%) |
 Unemployed | 2 (9%) |
 No data | 4 (17%) |
Social support | |
 Poor | 2 (9%) |
 Moderate | 11 (48%) |
 Good | 8 (35%) |
 No data | 2 (9%) |
TNM (T = tumor size, N = number of metastatic regional lymphnodes) | |
 T1(≤ 20 mm) | 14 (61%) |
 T2(21–50 mm) | 5 (22%) |
 T (> 50 mm) | 2 (9%) |
 T4 (any size with extension to chest wall or skin) | 0 (0%) |
 DCIS (ductal carcinoma in situ) | 2 (9%) |
 N0(0) | 12 (52%) |
 N1(1–3) | 8 (35%) |
 N2(4–9) | 3 (13%) |
 N3(> 9) | 0 (0%) |
Breast surgery | |
 Mastectomy | 9 (39%) |
 Conserving | 14 (61%) |
Adjuvant treatment | |
 Chemotherapy | 15 (65%) |
 Anti-HER2-therapy | 1 (4%) |
 Radiotherapy | 20 (87%) |
 Endocrine treatment | 17 (74%) |
Other diseases | |
 Hypertension | 6 (26%) |
 Cardiac disease | 1 (4%) |
 Diabetes | 2 (9%) |
 Asthma | 4 (17%) |
 Hypothyreosis | 1 (4%) |
 Allergies | 4 (17%) |
 Arthrosis | 4 (17%) |
 Other reported | 6 (26%) |